AAAAAA
Results:
1-12
|
Results: 12
Authors:
Musial, J
Undas, A
Undas, R
Brozek, J
Szczeklik, A
Citation: J. Musial et al., Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterollevels, THROMB HAEM, 85(2), 2001, pp. 221-225
Authors:
Musial, J
Undas, A
Gajewski, P
Jankowski, M
Sydor, W
Szczeklik, A
Citation: J. Musial et al., Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia, INT J CARD, 77(2-3), 2001, pp. 247-253
Authors:
Szczeklik, A
Sanak, M
Jankowski, M
Dropinski, J
Czachor, R
Musial, J
Axenti, I
Twardowska, M
Brzostek, T
Tendera, M
Citation: A. Szczeklik et al., Mutation A1298C of methylenetetrahydrofolate reductase: Risk for early coronary disease not associated with hyperhomocysteinemia, AM J MED G, 101(1), 2001, pp. 36-39
Authors:
Undas, A
Brummel, K
Musial, J
Mann, KG
Szczeklik, A
Citation: A. Undas et al., PIA2 polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury, CIRCULATION, 104(22), 2001, pp. 2666-2672
Authors:
Undas, A
Brummel, KE
Musial, J
Mann, KG
Szczeklik, A
Citation: A. Undas et al., Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation, CIRCULATION, 103(18), 2001, pp. 2248-2253
Authors:
Undas, A
Brummel, K
Musial, J
Mann, KG
Szczeklik, A
Citation: A. Undas et al., Blood coagulation at the site of microvascular injury: effects of low-doseaspirin, BLOOD, 98(8), 2001, pp. 2423-2431
Authors:
Melgar, T
Schubiner, H
Burack, R
Aranha, A
Musial, J
Citation: T. Melgar et al., A time-motion study of the activities of attending physicians in an internal medicine and internal medicine-pediatrics resident continuity clinic, ACAD MED, 75(11), 2000, pp. 1138-1143
Authors:
Undas, A
Undas, R
Musial, J
Szczeklik, A
Citation: A. Undas et al., A low dose of aspirin (75 mg/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300 mg/day), BL COAG FIB, 11(3), 2000, pp. 231-234
Authors:
Leonardi, GS
Houthuijs, D
Steerenberg, PA
Fletcher, T
Armstrong, B
Antova, T
Lochman, I
Lochmanova, A
Rudnai, P
Erdei, E
Musial, J
Jazwiec-Kanyion, B
Niciu, EM
Durbaca, S
Fabianova, E
Koppova, K
Lebret, E
Brunekreef, B
van Loveren, H
Citation: Gs. Leonardi et al., Immune biomarkers in relation to exposure to particulate matter: A cross-sectional survey in 17 cities of central Europe, INHAL TOXIC, 12, 2000, pp. 1-14
Authors:
Szczeklik, A
Musial, J
Undas, A
Gajewski, P
Gora, P
Swadzba, J
Jankowski, M
Citation: A. Szczeklik et al., Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia, J AM COL C, 33(5), 1999, pp. 1286-1293
Authors:
Undas, A
Sanak, M
Musial, J
Szczeklik, A
Citation: A. Undas et al., Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation, LANCET, 353(9157), 1999, pp. 982-983
Authors:
Jankowski, M
Dudek, D
Dubiel, JS
Musial, J
Citation: M. Jankowski et al., Successful coronary stent implantation in a patient with primary antiphospholipid syndrome, BL COAG FIB, 9(8), 1998, pp. 753-756
Risultati:
1-12
|